Both markets are reaching the maturity phase of growth and will register mid single-digit growth rates for the next five years, according to a new market report from Research & Markets.
Asia, parts of Africa and Latin America are poised to grow at double-digit rates owing to the increasing investment opportunities for companies in these immature markets and due to the improving healthcare facilities for animals. Countries like China, India, Australia and Brazil will be major contributors to the growth of the market.
The market is dominated by tier I players and is fairly consolidated with the top 5 players contributing close to 70 per cent of the share. New entrants face high barriers in entering this market as it is a capital-intensive industry with strict regulations.
This research report categorises the global animal/veterinary vaccines market on the basis of products, animal diseases and technology. These markets are broken down into segments and sub-segments, providing exhaustive value analysis for 2011, 2012, and 2013 as well as forecasts up to 2018. Each segment of the market is comprehensively analysed at a granular level, by geography (Europe, North America, Asia, and the Rest of the World), to provide in-depth information on the global scenario
